Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Direct oHSV Infection Induces DC Maturation and a Tumor Therapeutic Response.
Journal: Viruses
Published: July 07, 2025
Oncolytic HSV-IL27 expression improves CD8 T cell function and therapeutic activity in syngeneic glioma models.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
Oncolytic HSV-IL27 expression improves CD8 T cell function and therapeutic activity in syngeneic glioma models.
Journal: Journal for immunotherapy of cancer
Published: May 26, 2025
CAR T-cell and oncolytic virus dynamics and determinants of combination therapy success for glioblastoma.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
CAR T-cell and oncolytic virus dynamics and determinants of combination therapy success for glioblastoma.
Journal: Mathematical biosciences
Published: January 23, 2025
Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma.
Journal: Molecular therapy. Oncology
Published: October 04, 2024
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.
Journal: Frontiers in immunology
Published: June 29, 2024
Primary murine high-grade glioma cells derived from RCAS/tv-a diffuse glioma model reprogram naive T cells into immunosuppressive regulatory T lymphocytes.
Journal: Molecular therapy. Oncology
Published: June 10, 2024
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma.
Journal: Molecular therapy. Oncology
Published: May 24, 2024
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 27, 2024
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.
Journal: Frontiers in immunology
Published: February 10, 2024
Last Updated: 09/26/2026